Akimasa Tomida

Kyoto, 6028566, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A potent and selective PHOX2B promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy.

A potent and selective PHOX2B promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 03, 2026

Congenital Cutaneous Neurocristic Hamartoma of the Scalp with Poor Melanin Content.

Congenital Cutaneous Neurocristic Hamartoma of the Scalp with Poor Melanin Content.

Journal: International journal of surgical pathology

Published: April 15, 2025

Identifying miRNAs as predictive markers of good prognosis in neuroblastoma.

Identifying miRNAs as predictive markers of good prognosis in neuroblastoma.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: January 13, 2025

Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1.

Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1.

Journal: British journal of cancer

Published: January 01, 2025

A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

Journal: Molecular cancer therapeutics

Published: August 19, 2024

Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma.

Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma.

Journal: Pediatric blood & cancer

Published: May 31, 2023

Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant.

Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant.

Journal: Human genome variation

Published: January 24, 2022

Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma.

Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma.

Journal: Cancer science

Published: April 30, 2021

Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.

Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.

Journal: Molecular therapy oncolytics

Published: February 15, 2021

Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype.

Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype.

Journal: Molecular therapy. Methods & clinical development

Published: December 21, 2020

Pituitary apoplexy after cardiac surgery in a 14-year-old girl with Carney complex: a case report.

Pituitary apoplexy after cardiac surgery in a 14-year-old girl with Carney complex: a case report.

Journal: Endocrine journal

Published: September 06, 2019

Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma.

Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma.

Journal: Biochemical and biophysical research communications

Published: February 16, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026